Life Sciences

Wendy Paul, medication process architect at Seattle Children's Hospital, and Kyle Longhurst, product manager at Pariveda, preview their HIMSS23 discussion on a discharge medication error quality improvement project.

Epigenetic profiling creates opportunities for healthcare and the development of new drugs based on it, according to Mohamad Takwa, CEO of Epigenica, a Sweden-based company that focuses on the technology.

A look ahead with Judy Jiao, CIO of National Government Services, who also gives insights on precision medicine advancements and more.

Artificial intelligence can help free clinicians from administrative tasks so they can focus on one-on-one patient care, according to Dave Brown, CEO at QiiQ and Thanos Melitsiotis, CPO at QiiQ.

Data containing accurate medication history and prescription fill insights can lead to better patient outcomes, says Dr. Colin Banas, CMO of health IT company DrFirst.

First Databank president Bob Katter discusses the FDB Vela electronic prescribing network and how it will give patients with more control over their prescriptions.

Precision medicine is entering the mainstream, from genetic insights informing a range of specialties to primary care using pharmacogenomics, according to Dr. Joel Diamond of 2bPrecise.

Founder and CEO of b.well Connected Health Kristen Valdes believes that proper use of data can help healthcare organizations keep patient engagement high through more effective communication.

Mytonomy’s novel CRM employs high-quality video content to train patients to manage their chronic illnesses, according to CEO and cofounder Anjali Kataria.

This week's top stories include Physician Partners of America agreeing to pay $24.5M for allegedly billing for unnecessary services and other violations, and DCT company THREAD snapping up a platform for recruiting trial participants.